Elliott, Amanda
Walters, Raymond K. http://orcid.org/0000-0001-8422-6530
Pirinen, Matti http://orcid.org/0000-0002-1664-1350
Kurki, Mitja
Junna, Nella http://orcid.org/0000-0002-5953-5523
Goldstein, Jacqueline I.
Reeve, Mary Pat
Siirtola, Harri
Lemmelä, Susanna M.
Turley, Patrick http://orcid.org/0000-0003-3643-8605
Lahtela, Elisa
Mehtonen, Juha http://orcid.org/0000-0003-0554-4667
Reis, Kadri
Elnahas, Abdelrahman G.
Reigo, Anu
Palta, Priit
Esko, Tõnu
Mägi, Reedik http://orcid.org/0000-0002-2964-6011
Metspalu, Andres
Nelis, Mari
Milani, Lili
Hudjashov, Georgi
Siirtola, Haari
Lahtinen, Elisa
Palotie, Aarno http://orcid.org/0000-0002-2527-5874
Daly, Mark J. http://orcid.org/0000-0002-0949-8752
Widén, Elisabeth http://orcid.org/0000-0001-7108-2806
,
,
Article History
Received: 4 March 2023
Accepted: 7 November 2023
First Online: 5 January 2024
Competing interests
: R.K.W. has received honoraria from the Jackson Laboratory and sponsored travel from the Russell Sage Foundation. A.P. is the chief scientific officer for the FinnGen project, which has received funding from 13 pharmaceutical companies. M.J.D. is a founder of Maze Therapeutics. The remaining authors have no competing interests to declare.